Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give their informed consent to participate in the study
- People who have been recommended to receive a type of internal radiation treatment called intracavitary brachytherapy
- People whose cancer has been staged between FIGO Stage I and Stage IVA (confirm with trial site if unsure of your stage)
- People with a general health and activity level rated as ECOG 0 to 2, meaning they are able to carry out at least some daily activities
- People diagnosed with primary endometrial cancer, primary vaginal cancer, primary vulvar cancer, or recurrent gynaecological cancer
Who may not be able to join:
- People who are pregnant
- People for whom brachytherapy (internal radiation) is medically unsuitable or not recommended
- People who have inflammatory bowel disease, a history of abdominal adhesions (internal scar tissue), or a history of bowel obstruction
- People who have had a kidney transplant or have a horseshoe kidney (a specific kidney shape present from birth)
- People whose cancer involves significant spread into blood or lymph vessels (LVSI) or has grown into the side walls of the pelvis
- People whose treatment would require a more complex type of brachytherapy that involves needles placed directly into tissue (called interstitial brachytherapy)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marita Morgia, MD, Royal North Shore Hospital
Phone: 9463 1300
Australian sites
02 9463 1339
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Successful treatment of gynaecological HDR brachytherapy patients with 3D printed intracavitary applicators.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.